Dr. Woodruff was featured in an invited viewpoint in JAMA Oncology along with National Physicians Cooperative Leaders William Gradishar, MD and Kristin Smith, Fertility Preservation Patient Navigator.

Oncologists' Role in Patient Fertility Care: A Call to Action

Published Online: January 28, 2016

Dr. Sana Salih and colleagues have published a new paper, Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in Mice, on fertility preservation in young mice treated with chemotherapies.  Teresa Woodruff says that ‘fertoprotective therapies are the most important next step in research to protect ovarian function in women with cancer.’ Dr. Salih said that the most important points in the paper include ‘The fertoprotective drug, dexrazoxane (Dexra) pre-administration prevented ovarian damage and preserved fertility in pre-pubescent mice treated with doxorubicin (DXR) chemotherapy.

CCHMC Oncofertility Consortium Panel Presentation Nov 2015

The final day of the Oncofertility Conference was high-yield for attendees, who were fortunate to hear about best practices in oncofertility from the experts at Cincinnati Children’s Hospital Medical Center (CCHMC). Please find their efficient and thorough powerpoint uploaded above. Thank you to Drs. Breech, Hoefgen, Burns and their entire team!